Cell lipid metabolism modulators 2-bromopalmitate, D609, monensin, U18666A and probucol shift discoidal HDL formation to the smaller-sized particles: implications for the mechanism of HDL assembly

Autor: Fiona M. La, Michael C. Phillips, Angel X. Xiao, Duyen Quach, Chongren Tang, Daniel J. Rader, Cecilia Vitali, Nicholas N. Lyssenko, John S. Millar
Rok vydání: 2016
Předmět:
0301 basic medicine
Bridged-Ring Compounds
Apolipoprotein B
Probucol
Palmitates
Cell Line
03 medical and health sciences
chemistry.chemical_compound
Mice
Tangier disease
Thiocarbamates
Cell Line
Tumor

medicine
Animals
Humans
Monensin
Particle Size
Molecular Biology
Phospholipids
chemistry.chemical_classification
030102 biochemistry & molecular biology
biology
Apolipoprotein A-I
Cholesterol
Macrophages
Cell Membrane
nutritional and metabolic diseases
Thiones
Lipid metabolism
Cell Biology
medicine.disease
Lipid Metabolism
Norbornanes
030104 developmental biology
RAW 264.7 Cells
Biochemistry
chemistry
ABCA1
biology.protein
Fatty Acids
Unsaturated

lipids (amino acids
peptides
and proteins)

Androstenes
Lipoproteins
HDL

medicine.drug
Polyunsaturated fatty acid
Lipoprotein
ATP Binding Cassette Transporter 1
Zdroj: Biochimica et biophysica acta. 1861(12 Pt)
ISSN: 0006-3002
Popis: ATP-binding cassette transporter A1 (ABCA1) mediates formation of disc-shaped high-density lipoprotein (HDL) from cell lipid and lipid-free apolipoprotein A-I (apo A-I). Discoidal HDL particles are heterogeneous in physicochemical characteristics for reasons that are understood incompletely. Discoidal lipoprotein particles similar in characteristics and heterogeneity to cell-formed discoidal HDL can be reconstituted from purified lipids and apo A-I by cell-free, physicochemical methods. The heterogeneity of reconstituted HDL (rHDL) is sensitive to the lipid composition of the starting lipid/apo A-I mixture. To determine whether the heterogeneity of cell-formed HDL is similarly sensitive to changes in cell lipids, we investigated four compounds that have well-established effects on cell lipid metabolism and ABCA1-mediated cell cholesterol efflux. 2-Bromopalmitate, D609, monensin and U18666A decreased formation of the larger-sized, but dramatically increased formation of the smaller-sized HDL. 2-Bromopalmitate did not appear to affect ABCA1 activity, subcellular localization or oligomerization, but induced dissolution of the cholesterol-phospholipid complexes in the plasma membrane. Arachidonic and linoleic acids shifted HDL formation to the smaller-sized species. Tangier disease mutations and inhibitors of ABCA1 activity wheat germ agglutinin and AG 490 reduced formation of both larger-sized and smaller-sized HDL. The effect of probucol was similar to the effect of 2-bromopalmitate. Taking rHDL formation as a paradigm, we propose that ABCA1 mutations and activity inhibitors reduce the amount of cell lipid available for HDL formation, and the compounds in the 2-bromopalmitate group and the polyunsaturated fatty acids change cell lipid composition from one that favors formation of the larger-sized HDL particles to one that favors formation of the smaller-sized species.
Databáze: OpenAIRE